Skip to main content
. 2017 Feb 9;12(2):e0171301. doi: 10.1371/journal.pone.0171301

Table 4. SSTR2 IHC staining results—12 biopsies.

Patient ID Diagnosis Biopsy Source Staining Intensity Percent Cells Staining IHC Score Cells with IHC Staining SUVmax 68Ga-DOTATATE SUVmax 18F-FDG
153 ADC Resection 2 <5% 0 Inflam 2.1 5.1
137 ADC Resection 0 0 0 None 1.6 6.5
138 ADC Resection 1 <5% 0 NeoV 0.8 5.2
204 SCC Biopsy 1 30% 2 Inflam, NeoV 2.5 15.3
120 Benign Biopsy 0 0 0 None 0.8 3.4
70 Benign Biopsy 0 0 0 None 1.2 0.8
129 Benign Biopsy 0 0 0 None 1.2 0.8
101 SCC/ADC Resection 2 20% 2 Inflam 3.4 3.7
192 ADC Resection 1 <5% 0 Inflam 1.0 2.3
40 SCC FNA Bx 0 0 0 none 2.5 5.0
164 ADC FNA Bx 0 0 0 none 2.6 9.7
100 SCC FNA Bx 0 0 0 none 3.2 13.9

ADC, adenocarcinoma; SCC, squamous cell cancer; SCC/ADC, squamous cell cancer with adenosquamous features; Poorly diff, poorly differentiated lung cancer; Resection, tissue via surgical resection; Biopsy, core or wedge biopsy; FNA Bx, fine-needle aspiration biopsy; Inflam, inflammatory infiltration; LF, lymphoid follicles; NeoV, neovascular endothelium, pericytes.